Who founded cumulus-neuroscience?

cumulus-neuroscience was founded by Brian Murphy in 2015.

Who are cumulus-neuroscience's investors?

cumulus-neuroscience's investors include Dementia Discovery Fund, Clarendon Fund Managers Ltd., LifeArc Ventures.

Where is cumulus-neuroscience headquartered?

cumulus-neuroscience is headquartered in Belfast, GB.

cumulus-neuroscience

Belfast, GB · Founded 2015 · 35 employees on LinkedIn · 3 known investors

Find your way into cumulus-neuroscience

222 people in our graph share verified history with the cumulus-neuroscience team — schools, employers, funds. One of them is your warm intro.

Brian Cummingsunlockedknows Brian Murphy · together at cumulus-neuroscience (overlapped)

knows the team · via cumulus-neuroscience

×3knows the team · via Queen's University Belfast

×7knows the team · via Computer Science, Trinity College Dublin

NeuLogiq is a research platform for clinical trials that integrates tablet-based cognitive assessments, EEG monitoring, and real-world behavioral data to measure brain function changes. The platform serves biopharma sponsors and clinical research sites conducting central nervous system studies across phases 0-3.

AI & Machine Learning Biotech Digital Health Healthtech Medical Devices

Founders & leadership

cumulus-neuroscience was founded in 2015 by Brian Murphy.

Brian Murphy Co-Founder & CSOBrian Murphy holds education in engineering, cognitive science, computational neuroscience, and machine learning, with prior experience combining startup and research roles. As Co-Founder and Chief Scientific Officer of Cumulus Neuroscience, he applies data science methods to analyze brain activity data and cognitive states from neuroimaging technologies.

TinaCEO

Investors · 3

Dementia Discovery Fund✓ confirmed by cumulus-neuroscienceLondon

How we know: the company's own site · Not right? Tell us

Clarendon Fund Managers Ltd.listed by Clarendon Fund Managers Ltd.Belfast · $63K – $3.8M

How we know: Clarendon Fund Managers Ltd.'s portfolio page · Not right? Tell us

LifeArc Ventureslisted by LifeArc VenturesLondon

Companies House · registry record

View on Companies House ↗

Registered name: CUMULUS NEUROSCIENCE LIMITED
Company number: NI628481
Status: Active
Company type: Private limited company
Incorporated: 5 Jan 2015
Registered office: Unit 5, Concourse Building 3, Queens Road, Belfast, BT3 9DT
Nature of business (SIC): 62012 — Business and domestic software development
Previous names: BRAINWAVEBANK LTD. (2015–2020)
Accounts: last made up to 31 Dec 2025 · next due 30 Sept 2027
Confirmation statement: last made up to 12 Sept 2025 · next due 26 Sept 2026

Current officers · 6

Robert Ballantine — director, appointed 13 Sept 2025
Brian Cummings — director, appointed 30 Apr 2025
Graham Ferguson — director, appointed 12 Jun 2025
Brian Murphy — director, appointed 12 Jun 2025
Ricardo Sainz Fuertes — director, appointed 1 Jan 2026
Tina Sampath — director, appointed 1 Sept 2024

Source: Companies House public register · retrieved 13 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Frequently asked questions

What does cumulus-neuroscience do?: NeuLogiq is a research platform for clinical trials that integrates tablet-based cognitive assessments, EEG monitoring, and real-world behavioral data to measure brain function changes. The platform serves biopharma sponsors and clinical research sites conducting central nervous system studies across phases 0-3.
Who founded cumulus-neuroscience?: cumulus-neuroscience was founded by Brian Murphy in 2015.
Who are cumulus-neuroscience's investors?: cumulus-neuroscience's investors include Dementia Discovery Fund, Clarendon Fund Managers Ltd., LifeArc Ventures.
Where is cumulus-neuroscience headquartered?: cumulus-neuroscience is headquartered in Belfast, GB.